Research map: TUMOR BOARD: Fertility Sparing Surgery for Ovarian Clear Cell Carcinoma

Back to the article

Papers in this map

  1. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group · Dirk Timmerman · 2000 · 1007 citations · Cited by this paper
  2. Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancer · 2026 · Related
  3. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study · Ben Van Calster · 2014 · 515 citations · Cited by this paper
  4. Integration of Immuno-Nutritional Status into International Federation of Gynecology and Obstetrics Risk Stratification to Predict Chemotherapy Response and Survival in Gestational Trophoblastic Neoplasia · 2026 · Related
  5. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group · Dirk Timmerman · 2016 · 336 citations · Cited by this paper
  6. From intensification to selection: the next challenge in advanced or recurrent endometrial cancer · 2026 · Related
  7. Lymph node metastasis in stages I and II ovarian cancer: A review · Marjolein Kleppe · 2011 · 215 citations · Cited by this paper
  8. Pre-operative Nutritional Risk Screening 2002-based nomograms for predicting post-operative complications after cytoreductive surgery for ovarian cancer: a multi-center retrospective cohort study · 2026 · Related
  9. Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection · Toyomi Satoh · 2010 · 212 citations · Cited by this paper
  10. Giant vulvar plexiform neurofibroma in neurofibromatosis type 1 · 2026 · Related
  11. Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients · John K. Chan · 2007 · 165 citations · Cited by this paper
  12. Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study) · 2026 · Related
  13. ESGO / ISUOG / IOTA / ESGE Consensus Statement on preoperative diagnosis of ovarian tumors · Dirk Timmerman · 2021 · 111 citations · Cited by this paper
  14. Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study · 2026 · Related
  15. O-RADS US v2022: An Update from the American College of Radiology’s Ovarian-Adnexal Reporting and Data System US Committee · Lori M. Strachowski · 2023 · 111 citations · Cited by this paper
  16. Association between pembrolizumab-based therapy exposure and survival outcomes in metastatic or recurrent uterine carcinosarcoma: a multicenter real-world study · 2026 · Related
  17. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE · Philippe Morice · 2024 · 98 citations · Cited by this paper
  18. Recognizing confounders for the use and outcome associated with intrauterine manipulator during endometrial cancer surgery: a call for research · 2026 · Related
  19. Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? · Shiro Suzuki · 2008 · 94 citations · Cited by this paper
  20. External Validation of the IOTA Two-Step Strategy for Pre-operative Characterization of Adnexal Masses: Comparison with ADNEX, O-RADS and a Sequential Simple Rules–ADNEX Approach · 2026 · Related
  21. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000–2013 · Anton Oseledchyk · 2017 · 94 citations · Cited by this paper
  22. Thyroid Cancer Clinical Practice Guidelines in Oncology · Steven I. Sherman · 2005 · 67 citations · Cited by this paper
  23. Benign descriptors and ADNEX in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort · Chiara Landolfo · 2022 · 64 citations · Cited by this paper
  24. Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients · Kentaro Sugino · 2019 · 60 citations · Cited by this paper
  25. Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary · Jeong‐Yeol Park · 2016 · 56 citations · Cited by this paper
  26. Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up · Valerio Gallotta · 2021 · 54 citations · Cited by this paper
  27. Fertility-Sparing Surgery for Ovarian Cancer · Geoffroy Canlorbe · 2021 · 52 citations · Cited by this paper
  28. Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes · Dimitrios Nasioudis · 2018 · 44 citations · Cited by this paper
  29. Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma · Kazuaki Takahashi · 2020 · 44 citations · Cited by this paper
  30. Study of the correlation between tumor size and cyst rupture in laparotomy and laparoscopy for benign ovarian tumor: Is 10 cm the limit for laparoscopy? · Mitsuru Shiota · 2012 · 42 citations · Cited by this paper
  31. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary · Jennifer Jean Mueller · 2015 · 41 citations · Cited by this paper
  32. ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies · Lasai Barreñada · 2024 · 41 citations · Cited by this paper
  33. Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature · Dimitrios Nasioudis · 2020 · 37 citations · Cited by this paper
  34. Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis · Masato Yoshihara · 2019 · 34 citations · Cited by this paper
  35. A Systematic Review of Atypical Endometriosis-Associated Biomarkers · Ludovica Bartiromo · 2022 · 30 citations · Cited by this paper
  36. Fertility preservation in ovarian tumours · Federica Tomao · 2018 · 29 citations · Cited by this paper
  37. Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma · Eric I. Marks · 2019 · 23 citations · Cited by this paper
  38. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer · Zesi Liu · 2024 · 23 citations · Cited by this paper
  39. Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil’s dilemma for the surgeon: A systematic review and meta‐analysis · Koen De Decker · 2021 · 20 citations · Cited by this paper

Source: OpenAlex (CC0)